Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.
Lausanne, Switzerland, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Distalmotion - a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating ...
Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well as ambulatory surgery centers. The robotic assistant was cleared by the FDA ...
Lausanne, Switzerland, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Less than 30 days after receiving FDA De Novo marketing authorization, Distalmotion’s Dexter Surgical Robot has successfully treated the first ...
Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has ...
A team of surgeons at UC San Diego Health have become the first in the U.S. to use Distalmotion’s Dexter surgical robot in the outpatient setting. The robot, which earned FDA clearance just 30 days ...
Lausanne, Switzerland, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic ...
Lausanne, Switzerland, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results